Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Lung Cancer Treatments and Mutations, Hematopoietic Stem Cell Transplantation, Lung Cancer Research Studies, and Cancer Immunotherapy and Biomarkers.
Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study
333 | RITUXIMAB, HIGH‐DOSE METHOTREXATE PLUS ORELABRUTINIB AS INDUCTION THERAPY IN NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Efficacy and Safety of Roxadustat for Anemia in Patients Receiving Chemotherapy for Nonmyeloid Malignancies: A Randomized, Open-Label, Active-Controlled Phase III Study
Hormonal interventions in skin wounds – a mini review
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial
Identification of Risk Factors and Phenotypes of Surgical Site Infection in Patients After Abdominal Surgery
Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies
Design, synthesis and biological evaluation of phenanthridine amide and 1,2,3-triazole analogues against <i>Mycobacterium tuberculosis</i>
1998P Antitumor activity and safety profile of trilaciclib in Chinese patients with extensive-stage small cell lung cancer (ES-SCLC) receiving chemotherapy (TRACES): Updated results from TRACES
Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b Study
Apolipoprotein E mimetic peptide COG1410 combats pandrug-resistant Acinetobacter baumannii
Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis
Chemical Diversity and Antimicrobial Potential of Cultivable Fungi from Deep-Sea Sediments of the Gulf of Mexico
Hydride-induced Meisenheimer complex formation reflects activity of nitro aromatic anti-tuberculosis compounds
FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML
Role of c-Myc haploinsufficiency in the maintenance of HSCs in mice
2-Aryl benzazole derived new class of anti-tubercular compounds: Endowed to eradicate mycobacterium tuberculosis in replicating and non-replicating forms
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
Antimicrobial Lavandulylated Flavonoids from a Sponge-Derived Streptomyces sp. G248 in East Vietnam Sea
Injectable pegylated niclosamide (polyethylene glycol‐modified niclosamide) for cancer therapy
Mce3R Stress-Resistance Pathway Is Vulnerable to Small-Molecule Targeting That Improves Tuberculosis Drug Activities
Niclosamide inhibits vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in injured rat carotid arteries
Computer-aided discovery of two novel chalcone-like compounds active and selective against Leishmania infantum
Design, synthesis and characterization of poly (methacrylic acid-niclosamide) and its effect on arterial function
P2.03a-001 A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)